GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (NSE:INDGN) » Definitions » EV-to-EBIT

Indegene (NSE:INDGN) EV-to-EBIT : 23.37 (As of May. 16, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Indegene EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Indegene's Enterprise Value is ₹131,168 Mil. Indegene's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹5,613 Mil. Therefore, Indegene's EV-to-EBIT for today is 23.37.

The historical rank and industry rank for Indegene's EV-to-EBIT or its related term are showing as below:

NSE:INDGN' s EV-to-EBIT Range Over the Past 10 Years
Min: 19.88   Med: 25.06   Max: 29.62
Current: 23.36

During the past 5 years, the highest EV-to-EBIT of Indegene was 29.62. The lowest was 19.88. And the median was 25.06.

NSE:INDGN's EV-to-EBIT is ranked worse than
65.03% of 449 companies
in the Healthcare Providers & Services industry
Industry Median: 16.88 vs NSE:INDGN: 23.36

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Indegene's Enterprise Value for the quarter that ended in Mar. 2025 was ₹123,092 Mil. Indegene's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹5,613 Mil. Indegene's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 4.56%.


Indegene EV-to-EBIT Historical Data

The historical data trend for Indegene's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene EV-to-EBIT Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
EV-to-EBIT
- - - - 21.93

Indegene Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 24.90 27.61 26.04 21.93

Competitive Comparison of Indegene's EV-to-EBIT

For the Health Information Services subindustry, Indegene's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indegene's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Indegene's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Indegene's EV-to-EBIT falls into.


;
;

Indegene EV-to-EBIT Calculation

Indegene's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=131167.874/5613
=23.37

Indegene's current Enterprise Value is ₹131,168 Mil.
Indegene's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,613 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indegene  (NSE:INDGN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Indegene's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=5613/123091.628
=4.56 %

Indegene's Enterprise Value for the quarter that ended in Mar. 2025 was ₹123,092 Mil.
Indegene's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,613 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indegene EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Indegene's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Indegene Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines